Satio Inc.

The SatioPatch™ Platform decentralizes care by Transforming Workflow for diagnostics, drug delivery and biometrics integration. Lab quality at home consumer-based diagnosis is enabled through a convenient and simple to use patch utilizing a wide variety of technologies to address an increasing demand for rapid, point of care diagnosis. This adhesive patch platform is being developed for drug and vaccine delivery with a reusable applicator and low-cost disposable with pressure sensors. The platform is designed to provide stable (through adhesive patch) and controlled (through motors) delivery to match the needs of a wide range of drugs and to improve the experience for chronic disease patients with recurring injections. Radical innovations in work flow include a remote tele-injection capability (video, biometrics, remote control, go/no-go sensors, EHR transmission) and a fully automated delivery through the intradermal or subcutaneous route of administration at Therapeutic Dose levels. Products not yet approved in US or other territories.